First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis
Phase 2
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: BuMA Supreme Biodegradable drug coating coronary stent systemDevice: Resolute Integrity durable polymer stent system
- First Posted Date
- 2014-09-11
- Last Posted Date
- 2020-07-28
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 168
- Registration Number
- NCT02236975
- Locations
- 🇳🇱
UMCG, Groningen, Netherlands
🇳🇱Maasstad Hospital, Rotterdam, Netherlands
🇵🇹Santa Maria University Hospital, Lisboa, Portugal
Comparison of BuMA eG Based BioDegradable Polymer Stent With EXCEL Biodegradable Polymer Sirolimus-eluting Stent in "Real-World" Practice
Phase 4
Completed
- Conditions
- Coronary Artery Disease
- Interventions
- Device: EXCELDevice: BuMA
- First Posted Date
- 2013-12-20
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 2348
- Registration Number
- NCT02017275
- Locations
- 🇨🇳
Fuwai hospital, Beijing, China
BuMA OCT Study(A Comparative Evaluation of the Extent of Neointima Formation at 3 Months After Implantation Using OCT)
Not Applicable
Completed
- Conditions
- Coronary Heart DiseaseSilent Myocardial IschemiaUnstable Angina PectorisStable Angina Pectoris
- Interventions
- Device: BuMA stentDevice: EXCEL stent
- First Posted Date
- 2012-12-19
- Last Posted Date
- 2016-03-14
- Lead Sponsor
- Sino Medical Sciences Technology Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT01752582
- Locations
- 🇨🇳
Fuwai Hospital, Chinese Academy of Medical Science, BeiJing, Beijing, China
© Copyright 2025. All Rights Reserved by MedPath